Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 3:5:1451768.
doi: 10.3389/falgy.2024.1451768. eCollection 2024.

Asthma management in the digital age

Affiliations
Review

Asthma management in the digital age

Ilan Y Bocian et al. Front Allergy. .

Abstract

Asthma affects 25 million people in the United States, and its prevalence is increasing. Access to care and adherence to prescribed asthma-treatment programs remain the principal formidable challenges for asthma management. Telemedicine offers substantial opportunities for improved asthma care of patients across the full range of socioeconomic strata. Ever-improving digital tools for asthma assessment and treatment are key components of telemedicine platforms for asthma management. These include a variety of remote patient-monitoring devices, digital inhaler systems, and mobile-health applications that facilitate ongoing assessment and adherence to treatment protocols. Digital tools for monitoring treatment focus on tracking medication use, inhalation technique, and physiological markers such as peak-flow rate and pulse-oximetry. Telemedicine visits allow for elements of assessment via video, approximating or duplicating many aspects of in-person visits, such as evaluating a patient's general appearance, breathing effort, and cough. Challenges remain in ensuring equitable access to these technologies, especially in rural and low-income areas, and in maintaining patient privacy and data security in digital platforms.

Keywords: asthma; digital tools; healthcare accessibility; remote patient monitoring; telemedicine.

PubMed Disclaimer

Conflict of interest statement

RSC receives grant support from the Consortium for Food Allergy Research (CoFAR), National Institute of Allergy and Infectious Disease (NIAID), Food Allergy Research & Education (FARE), and is an advisory board member for Alladapt Immunotherapeutics, Novartis, Intrommune Therapeutics, Phylaxis, and Genentech. SS reports grants from NIH, Regeneron, DBV Technologies, Aimmune, Novartis, CoFAR, and FARE. She is an Advisory member at Genentech and DBV Technologies. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interes.

Similar articles

Cited by

References

    1. Myrick K, Mahar M, DeFrances C. Telemedicine use among physicians by physician specialty: United States, 2021. Hyattsville: Centers for Disease Control and Prevention (U.S.) (2024). p. 1. Available online at: https://stacks.cdc.gov/view/cdc/141934 (cited August 15 2024). - PubMed
    1. WHO Global Observatory for eHealth. Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on EHealth. Geneva: World Health Organization; (2010). p. 93. Available online at: https://iris.who.int/handle/10665/44497
    1. Bajowala SS, Shih J, Varshney P, Elliott T. The future of telehealth for allergic disease. J Allergy Clin Immunol Pract. (2022) 10(10):2514–23. 10.1016/j.jaip.2022.08.022 - DOI - PMC - PubMed
    1. Mosnaim GS, Greiwe J, Jariwala SP, Pleasants R, Merchant R. Digital inhalers and remote patient monitoring for asthma. J Allergy Clin Immunol Pract. (2022) 10(10):2525–33. 10.1016/j.jaip.2022.06.026 - DOI - PubMed
    1. Ansary AM, Martinez JN, Scott JD. The virtual physical exam in the 21st century. J Telemed Telecare. (2021) 27(6):382–92. 10.1177/1357633X19878330 - DOI - PubMed

LinkOut - more resources